Official Louisiana State Websites use .la.gov 
Secure .gov websites use HTTPS 
Notice of Intent: Newborn Screening
The proposed rule to include Spinal Muscular Atrophy (SMA), Mucopolysaccharidosis (MPS I), and Glycogen Storage Diseases Type II (Pompe Disease) to the Louisiana Newborn Screening Panel.
LDH News
-
-
Notice of Intent: Consumable Hemp Products
For the registration of Consumable Hemp Products
-
Notice of Intent: Immunization Schedule
Adding Covid19 vaccine to the Immunization Schedule
-
Notice of Intent: Title 46 Part XXXVIII
-
NOTICE OF INTENT: Automated External Defibrillators
Under the authority of R.S. 36:254(B)(7) and in accordance with R.S. 49:950 et seq., the Administrative Procedure Act, notice is hereby given that the Louisiana Department of Health, Office of Public Health (LDH-OPH) intends to amend Chapter 61 (Automated External Defibrillators) of Subpart 3 (Licensing and Certification) of Part I (General Administration) of Title 48 (Public Health—General) of the Louisiana Administrative Code (LAC). The proposed amendments are necessary to update the LAC to match the amended R.S. 40:1137.3.
-
NOTICE OF INTENT: Mandatory Tuberculosis Testing Revisions
This proposed rule eliminates the current requirement for annual TB testing for most employees, students or volunteers at any medical or 24-hour residential facility requiring licensing by the Louisiana Department of Health (LDH), or at any LDH-OPH parish health unit or an LDH-OPH out-patient health care facility.
-
NOTICE OF INTENT: Industrial Hemp-Derived Cannabidiol Product Registration
This proposed rule change is required to comply with Act 344 of the 2020 Regular Session of the Louisiana Legislature. The proposed rule change will update LDH-OPH’s currently existing rule pertaining to industrial hemp-derived Cannabidiol products (IHDCP).
-
NOTICE OF INTENT: Covid-19 Disease Reporting Requirements
Under the authority of R.S. 40: 4 and 40:5, and in accordance with R.S. 49:950 et seq., the Administrative Procedure Act, notice is hereby given that the state health officer, acting through the Louisiana Department of Health, Office of Public Health (LDH-OPH), intends to amend §§105 and 107 of Part II (The Control of Diseases) of Title 51 (Public Health-Sanitary Code) of the Louisiana Administrative Code. This rule is being proposed to include COVID-19 in the list of diseases and conditions hereby declared reportable as a Class A disease or condition.
-
NOTICE OF INTENT: Certification of Laboratories Performing Water Analysis
Under the authority of R.S. 36:254(B)(7) and in accordance with R.S. 49:950 et seq., the Administrative Procedure Act, the Department of Health, Office of Public Health (LDH-OPH), has amended Chapter 80 (Accreditation of Laboratories Performing Drinking Water Analyses) of Subpart 28 (Drinking Water Laboratories) of Part V (Preventive Health Services) of Title 48 (Public Health?General) of the Louisiana Administrative Code (LAC). The amendments are necessary to withdraw the LDH-OPH Laboratory Certification Program from The NELAC Institute (TNI), the National Environmental Laboratory Accreditation Program (NELAP).
-
NOTICE OF INTENT: Louisiana Immunization Network/LINKS
The newly adopted law authorizes LDH-OPH to maintain the immunization record of clients 21 years of age and older within the state’s immunization registry, and generally requires that all vaccinations administered in the state of Louisiana be entered into the LINKS system. Act 192 of 2019 refers to the state’s immunization registry as the Louisiana Immunization Network, also known as LINKS.
-
NOTICE OF INTENT: Registration of Foods, Drugs, Cosmetics and Prophylactic Devices - Regulatory Framework Oversight
Implements a regulatory framework for industrial hemp-derived cannabidiol products (IHDCP) in accordance with directives of Subsection J of Section 1382 of Title 3 of the Revised Statutes of 1950, enacted as part of Act 164 of the 2019 Louisiana Legislature.
-
NOTICE OF INTENT: Emergency Preparedness Activities
Enacted to authorize hospitals and other health care providers to use protected health information for the sole purpose of participating in emergency preparedness training, which includes testing the functionality of the AtRisk Registry.